Oura is pursuing a public offering that would value the wearable ring maker at $2.2 billion, but most of the early capital is expected to go to existing shareholders rather than fund new growth. The move highlights investor appetite for health-focused hardware even as consumer device companies face tighter margins, longer replacement cycles, and more crowded competition from smartwatches and other biometric wearables. For Oura, the listing could mark a transition from startup to public-market company, though the emphasis on secondary sales may raise questions about how much new money will actually flow into product development and international expansion.
Oura has built one of the better-known subscription-driven wearable businesses around its health and sleep tracking ring, but the path to public markets comes with tradeoffs. A high-profile listing can validate a category, broaden access to capital, and give early investors a way to realize gains. At the same time, it forces a company to operate with public-company discipline: predictable growth, cleaner unit economics, and a clearer story around retention and lifetime value.
The valuation itself suggests the market still sees potential in ambient health tracking, especially for a form factor that avoids the screen-heavy design of most smartwatches. But investors will also be watching whether Oura can expand beyond its core audience, maintain subscription revenue, and defend against larger players that can bundle health features with phones, watches, and cloud services. In short, the IPO is as much a test of consumer-wearables durability as it is of Oura's specific execution.
